MiniMed Group, Inc. (MMED)
NASDAQ: MMED · Real-Time Price · USD
16.70
-0.22 (-1.30%)
Jul 21, 2026, 4:00 PM EDT - Market closed
MiniMed Group Balance Sheet
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
Fiscal Quarter | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q4 2024 | Q3 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 24, 2026 | Jan '26 Jan 23, 2026 | Oct '25 Oct 24, 2025 | Jul '25 Jul 24, 2025 | Apr '25 Apr 25, 2025 | Jan '25 Jan 24, 2025 | Apr '24 Apr 26, 2024 | Jan '24 Jan 26, 2024 | Apr '23 Apr 28, 2023 | Jan '23 Jan 28, 2023 |
Cash & Equivalents | 298 | 10 | 8 | 8 | 11 | 11 | 54 | 54 | 58 | 58 |
Cash & Short-Term Investments | 298 | 10 | 8 | 8 | 11 | 11 | 54 | 54 | 58 | 58 |
Cash Growth | 2609.09% | -9.09% | -85.19% | -85.19% | -81.03% | -81.03% | - | - | - | - |
Accounts Receivable | 200 | 653 | 588 | 588 | 570 | 570 | 507 | 507 | 430 | 430 |
Other Receivables | 455 | - | - | - | - | - | - | - | - | - |
Total Trade Receivables | 655 | 653 | 588 | 588 | 570 | 570 | 507 | 507 | 430 | 430 |
Inventory | 341 | 408 | 361 | 361 | 311 | 311 | 292 | 292 | 298 | 298 |
Other Current Assets | 54 | 37 | 33 | 33 | 48 | 48 | 43 | 43 | 58 | 58 |
Total Current Assets | 1,348 | 1,108 | 991 | 991 | 939 | 939 | 895 | 895 | 844 | 844 |
Net Property, Plant & Equipment | 711 | 701 | 755 | 755 | 706 | 706 | 636 | 636 | 589 | 589 |
Other Intangible Assets | 107 | 113 | 119 | 119 | 132 | 132 | 161 | 161 | 194 | 194 |
Goodwill | 2,256 | 2,256 | 2,256 | 2,256 | 2,255 | 2,255 | 2,255 | 2,255 | 2,255 | 2,255 |
Other Long-Term Assets | 208 | 165 | 168 | 168 | 169 | 169 | 147 | 147 | 138 | 138 |
Total Assets | 4,630 | 4,343 | 4,289 | 4,289 | 4,201 | 4,201 | 4,094 | 4,094 | 4,020 | 4,020 |
Accounts Payable | 300 | 303 | 242 | 242 | 205 | 205 | 190 | 190 | 213 | 213 |
Accrued Expenses | 402 | 393 | 318 | 318 | 504 | 504 | 328 | 328 | 306 | 306 |
Total Current Liabilities | 702 | 696 | 560 | 560 | 710 | 710 | 518 | 518 | 519 | 519 |
Other Long-Term Liabilities | 317 | 184 | 170 | 170 | 162 | 162 | 128 | 128 | 99 | 99 |
Total Long-Term Liabilities | 317 | 184 | 170 | 170 | 162 | 162 | 128 | 128 | 99 | 99 |
Total Liabilities | 1,019 | 881 | 729 | 729 | 871 | 871 | 647 | 647 | 618 | 618 |
Common Stock | 3 | - | - | - | - | - | - | - | - | - |
Additional Paid-in Capital | 3,736 | - | - | - | - | - | - | - | - | - |
Accumulated Other Comprehensive Income | -12 | 14 | 8 | 8 | 3 | 3 | -16 | -16 | -9 | -9 |
Retained Earnings | -116 | 3,449 | 3,551 | 3,551 | 3,328 | 3,328 | 3,464 | 3,464 | 3,411 | 3,411 |
Shareholders' Equity | 3,611 | 3,462 | 3,560 | 3,560 | 3,330 | 3,330 | 3,448 | 3,448 | 3,402 | 3,402 |
Total Liabilities & Equity | 4,630 | 4,343 | 4,289 | 4,289 | 4,201 | 4,201 | 4,094 | 4,094 | 4,020 | 4,020 |
Net Cash (Debt) | 298 | 10 | 8 | 8 | 11 | 11 | 54 | 54 | 58 | 58 |
Net Cash Growth | 2609.09% | -9.09% | -85.19% | -85.19% | -81.03% | -81.03% | - | - | - | - |
Net Cash Per Share | 1.11 | 0.04 | 0.03 | 0.03 | 0.04 | 0.04 | - | - | - | - |
Book Value | 3,611 | 3,462 | 3,560 | 3,560 | 3,330 | 3,330 | 3,448 | 3,448 | 3,402 | 3,402 |
Book Value Per Share | 13.47 | 13.69 | 14.08 | 14.08 | 13.17 | 13.17 | - | - | - | - |
Tangible Book Value | 1,248 | 1,093 | 1,185 | 1,185 | 943 | 943 | 1,032 | 1,032 | 953 | 953 |
Tangible Book Value Per Share | 4.65 | 4.32 | 4.69 | 4.69 | 3.73 | 3.73 | - | - | - | - |